| abstract |
The present invention relates to chemical entities useful as ubiquitin-specific peptidase (USP30) inhibitors, pharmaceutical compositions comprising the chemical entities, and methods of using the chemical entities. The chemical entities according to the invention may be useful in the treatment of a disease, disorder or condition involving mitochondrial dysfunction, including neurodegenerative diseases, motor neuron diseases, metabolic disorders and cancers. among other diseases. |